Agree. It sounds like, if the trial is abandoned, they would develop another indication (e.g., TBI). And it wasn't entirely clear that they had paused the trial. Thanks for clearing this up.
Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-174
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 532 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 8695 | 1 |
View Market Depth
| Last trade - 15.02pm 09/08/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable